Department of Hematology, Tokyo University of Science, Tokyo 125-8585, Japan
Mini Review
Advancing Immunotherapy: Harnessing Innate Immune Cells for Adult T-cell Leukemia-lymphoma Treatment
Author(s): Rosa Murata*
The relentless pursuit of effective treatments for Adult T-Cell Leukemia-Lymphoma (ATLL) has led to the exploration of innovative immunotherapeutic
strategies. This study delves into the development of a novel approach, namely, the utilization of innate immune cells as a foundation for
immunotherapy against ATLL. Harnessing the potent capabilities of these immune effectors, particularly Natural Killer (NK) cells and macrophages,
offers a promising avenue for targeted and sustainable ATLL treatment. The research outlines the engineering and optimization of innate
immune cells to enhance their specificity and cytotoxicity against ATLL cells while minimizing off-target effects. In-depth preclinical investigations
demonstrate the efficacy of this immunotherapeutic strategy, highlighting its potential as a next-generation treatment modality for ATLL patients.
The fi.. Read More»
DOI:
10.37421/2469-9756.2023.9.211
Immunochemistry & Immunopathology received 174 citations as per Google Scholar report